Eminence Business Media to organise Pharma Authors Round Table in Mumbai
Project managers are invited to submit their abstracts of white papers by or before January 7, 2020 Eminence Business Media is…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Uncategorized
Routine pneumococcal vaccination rates remain high in children, but subpar in elderly: GlobalData…
The company’s latest report, ‘Pneumococcal Vaccines: Epidemiology Forecast to 2028’, reveals that the average pediatric…
SCHOTT Glass strenghtens India facility as Asian hub
With investments of close to €47 million in India over two years, global pharmaceutical glass manufacturer SCHOTT AG clearly sees…
‘We consider the ever-evolving needs of the industry as an opportunity to do more and serve better’
Ashok Kumar Prusty, Executive Vice President, Bry-Air reveals more about his company’s offerings for the pharma sector, in an…
SPARC enters into licensing deal with CMS to develop and commercialise products
The initial term of the agreement shall be 20 years from the date of first commercial sale of each product in the territory and…
TB Alliance and Macleods partners for new therapy for highly drug-resistant TB
Non-profit product development partnership and generic manufacturer agree to produce new TB drug for countries with high incidence…
At Rs 58.8 cr, Murali of Divi’s Lab highest paid Indian pharma executive
The percentage increase in the median remuneration for the staff of the firm for FY19 was 3.96 per cent
Gap analysis of some key stakeholders of Indian pharmacovigilance
On World Pharmacovigilance Day, Dr J Vijay Venkatraman, Managing Director & CEO, Oviya MedSafe, takes stock of the country’s…
Eurolife takes over TEVA’s Intravenous Infusions plant in Hungary
With this takeover, Eurolife has emerged as the first Indian Company in the Intravenous Infusions business to set up manufacturing…
Intas launches Romiplostim in India
With this, the drug firm makes therapy for chronic immune thrombocytopenia (ITP) more accessible to patients
Pharma industry gearing up to rapidly changing regulatory norms
By 2020, many branded medicines are going off-patent and there will be an ocean of opportunities for big- and medium-sized pharma…
Vizag Pharma Summit deliberates on the future of Brand India Pharma
The theme of the maiden Vizag Pharna Summit was Shaping the future of Brand India Pharma Usha Sharma -- Vizag After the…
The government should consider it as national emergency-Dr B Krishna Murthy
Self-sufficiency in bulk drugs remains a distant dream as India remains import dependent with over dependence on China, even for…
There is a need to focus on skill development-Dr Sanjit Singh Lamba
Emerging economies have been struggling with the absence of quality healthcare, and the biggest challenge in healthcare today…
Changing the mindset for education can definitely be a game changer-KV V Raju
First, it is important to understand the comparison between India and China's economy from a business
perspective. China is now…
How pharma companies can minimise API dependency from China?-Anant Barbadikar
Pharma Companies, over a period of last 25 years, have gradually started depending on China. Many companies started buying APIs.…
Indian cos need to explore on putting up facilities in dedicated pockets-Suresh Kamath
Indian pharma companies have a lot of manufacturing sites across the country. However, the economics of scale of units here is…
Measures must focus on domestic players -Madan Mohan Reddy
The pharma sector in India depends heavily on large-scale imports of Active Pharmaceutical ingredients/intermediate products…
China manufactures most of the bulk drugs pharma industry requires-Ravi Uday Bhaskar
India has exported pharmaceuticals worth $200.02 million in FY18, with a recorded growth of 37.52 per cent.
While we have imported…
Making India Pharma Inc self sufficient
Governments across the world are strategising to ensure accessibility and affordability of drugs with increasing healthcare spends…